Antithrombotic treatment and atrial fibrillation.
- 12 December 1992
- Vol. 305 (6867) , 1445-1446
- https://doi.org/10.1136/bmj.305.6867.1445
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)BMJ, 1992
- Randomized Trials of Warfarin for Atrial FibrillationNew England Journal of Medicine, 1992
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- ATRIAL FIBRILLATION AND ANTITHROMBOTIC PROPHYLAXIS: A PROSPECTIVE META-ANALYSISThe Lancet, 1989
- Duration of atrial fibrillation and imminence of stroke: the Framingham study.Stroke, 1983
- Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.Stroke, 1983
- RELATION OF ATRIAL FIBRILLATION AND HIGH HAEMATOCRIT TO MORTALITY IN ACUTE STROKEThe Lancet, 1983